Role of alendronate and risedronate in preventing and treating osteoporosis

Margaret L. Peters, PharmD
Department of Pharmacy, Cleveland Clinic

Mandy Leonard, PharmD
Drug information specialist, Department of Pharmacy, Cleveland Clinic

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Address: Mandy Leonard, PharmD, Department of Pharmacy, Hb3, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; leonarm@ccf.org

Dr. Licata is a consultant for Merck and has received grant or research support from the Merck, Lilly, Pfizer, Takeda, and Novartis companies.

Margaret L. Peters, PharmD
Department of Pharmacy, Cleveland Clinic

Mandy Leonard, PharmD
Drug information specialist, Department of Pharmacy, Cleveland Clinic

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Address: Mandy Leonard, PharmD, Department of Pharmacy, Hb3, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; leonarm@ccf.org

Dr. Licata is a consultant for Merck and has received grant or research support from the Merck, Lilly, Pfizer, Takeda, and Novartis companies.

Margaret L. Peters, PharmD
Department of Pharmacy, Cleveland Clinic

Mandy Leonard, PharmD
Drug information specialist, Department of Pharmacy, Cleveland Clinic

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Address: Mandy Leonard, PharmD, Department of Pharmacy, Hb3, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; leonarm@ccf.org

Dr. Licata is a consultant for Merck and has received grant or research support from the Merck, Lilly, Pfizer, Takeda, and Novartis companies.